Search

Agreement is part of Daiichi Sankyos five-year mid-term strategy to transform to a structure primarily focused on patented drugs Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) [...]

TOKYO & BASKING RIDGE, N.J.: Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) have entered into an agreement with Cosette Pharmaceuticals, Inc. whereby Daiichi Sankyo divested and [...]

TOKYO & BASKING RIDGE, N.J.: Daiichi Sankyo has issued the following news release: Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) have entered into an agreement with [...]

BRIDGEWATER, N.J.: Cosette Pharmaceuticals, Inc. has issued the following news release: Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that it has closed a transaction to acquire [...]

Daiichi Sankyo Company Limited and Daiichi Sankyo Inc (hereafter, Daiichi Sankyo) have entered into an agreement with Cosette Pharmaceuticals Inc whereby Daiichi Sankyo divested and Cosette acquired rights for manufacturing, commercialization, and certain other rights for the following products in the US: AZOR (amlodipine/olmesartan medoxomil); BENICAR (olmesartan medoxomil); BENICAR HCT (olmesartan medoxomil/hydrochlorothiazide); EFFIENT (prasugrel); EVOXAC (cevimeline HCL); TRIBENZOR (olmesartan medoxomil/amlodipine/hydrochlorothiazide); WELCHOL (colesevelam HCL) tablets; WELCHOL (colesevelam HCL) Oral Suspension. No other products are impacted by this agreement and no roles will be eliminated at Daiichi Sankyo related to this agreement. The agreement outlines a 30-month transition period during which Daiichi Sankyo and Cosette Pharmaceuticals will transfer responsibilities for the manufacture, supply and commercialization of these products, including quality assurance, pharmacovigilance and regulatory matters. Original source: Daiichi Sankyo Co Ltd, website: http://www.daiichisankyo.com/, Copyright Daiichi Sankyo Company Limited 2022., mergers and acquisitions; patents and technical know-how; amlodipine; AZOR; BENICAR HCT; cevimeline; cevimeline hydrochloride; colesevelam hydrochloride; colesevelam hydrochloride; hydrochlorothiazide; olmesartan medoxomil; olmesartan medoxomil; prasugrel; prasugrel; TRIBENZOR; Cosette Pharmaceuticals; Daiichi [...]

Lupin announced that it has received approval for its Colesevelam Hydrochloride Tablets, 625 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of [...]

Colesevelam Hydrochloride Tablets (RLD: Welchol) had an annual sales of approximately $159 million in the US Lupin is currently trading at Rs. 987.90, up by 15.70 points or 1.61% from [...]

Mumbai: Ramesh Kumar Global financial broking firm has issued the following news release: Lupin has received approval for its Colesevelam Hydrochloride Tablets, 625 mg, from the United States Food and [...]

Colesevelam Hydrochloride Tablets (RLD: Welchol) had an annual sales of approximately $159 million in the US Lupin has received approval for its Colesevelam Hydrochloride Tablets, 625 mg, from the United [...]

Mumbai: India Infoline has issued the following press release: Sun Pharma and Glenmark have already launched their generics of this drug. The Welchol brand and its generics had US sales [...]

Dr Reddy's Laboratories Ltd. has announced the launch of a cholesterol-lowering medication Colesevelam HCl Tablets in the United States market approved by the US Food and Drug Administration (USFDA). The [...]

The WELCHOL brand and generic had US sales of around $471 million MAT for the most recent twelve months ending in August 2018 Dr. Reddy's Laboratories has launched Colesevelam HCI [...]

HYDERABAD, India & PRINCETON, N.J. -- Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as 'Dr. Reddy's') today announced that it [...]

ENPNewswire-July 23, 2018--Glenmark Pharmaceuticals receives ANDA approval for Colesevelam Hydrochloride for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet (C)2018 ENPublishing - http://www.enpublishing.co.uk Release date- 20072018 - Mumbai - Glenmark Pharmaceuticals [...]

ENPNewswire-July 20, 2018--Glenmark Pharmaceuticals receives ANDA approval for Colesevelam Hydrochloride for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet (C)2018 ENPublishing - http://www.enpublishing.co.uk Release date- 19072018 - Mumbai - Glenmark Pharmaceuticals [...]

Glenmark Pharmaceuticals has received final approval from the US health regulator for Colesevelam Hydrochloride for oral suspension, used to lower cholesterol levels in the blood. The approval has been granted [...]

Mumbai: India Infoline has issued the following press release: gWelchol is a cholesterol lowering drug and the current approvals in two strengths has an addressable market size of $73mn.Glenmark Pharma [...]

Mumbai: Indsec Securities & Finance Ltd has issued the following press release: Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food & Drug [...]

The company's current portfolio consists of 138 products authorized for distribution in the US marketplace Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & [...]

The company's current portfolio consists of 138 products authorized for distribution in the US marketplace Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & [...]

Mumbai: India Infoline has issued the following press release: Last week Sun Pharma had launched authorized generic of this drug in the US market. The drug nevertheless is significantly large, [...]

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Colesevelam Hydrochloride Tablets, 625 mg, the generic version of [...]

Glenmark Pharma has received a final USFDA approval for Colesevelam HCL 625mg i.e. Welchol. Glenmark has also said that it has already commenced supplies of the product to the US [...]

The company has already commenced supplies of the product to the US market Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug [...]

Mumbai: Indsec Securities & Finance Ltd has issued the following press release: Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food & Drug [...]

Colesevelam Hydrochloride tablets is generic version of Welchol tablets Glenmark Pharma said it has received final approval from the US health regulator for Colesevelam Hydrochloride tablets, 625 mg, the generic [...]

BRIDGEWATER: Amneal Pharmaceuticals, Inc. has issued the following news release: Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a specialty pharmaceutical company, today announced it has received final U.S. Food and Drug Administration [...]

Welchol Tablets recorded US sales of approximately $520 million for the 12 months ending March 2018, as per IQVIA Sun Pharmaceutical Industries is currently trading at Rs. 484.10, up by [...]

Welchol Tablets recorded US sales of approximately $520 million for the 12 months ending March 2018, as per IQVIA Sun Pharmaceutical Industries through one of its wholly owned subsidiaries has [...]